Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Translational pharmacogenomics research from molecule to bedside

The Carney Centre for Pharmacogenomics is a collaboration between research groups based at the University of Otago, Christchurch.

Together, we span a wide range of clinical, pharmacological and genetic expertise. As a result we have a strongly collaborative, multidisciplinary approach to pharmacogenomic research.

Our research

Our current research programmes focus on several aspects of pharmacogenetics, pharmacogenomics and related topics. For example, we are studying:

  • Potential genetic factors underlying serious adverse reactions, or unusual responses to drugs
  • Genome-wide gene expression effects of the mood stabiliser drug sodium valproate, in a brain cell line
  • Epigenetic effects of drugs
  • Molecular basis of micronutrient treatment in mental disorders

We use a range of methods for these projects, including DNA sequence analysis of specific pharmacogenes, application of genome-wide methods such as whole exome and whole genome sequencing, as well as RNA-sequencing, methylome analysis, and application of novel technologies such as nanopore DNA sequencing.

Learn more about the research undertaken by the Carney Centre for Pharmacogenomics.


Jim and Mary Carney_thumbnail

Our benefactors

The Carney Centre is named in honour of our benefactors, the Jim and Mary Carney Charitable Trust

Martin Kennedy thumbnail

Bad reactions

We are investigating how genetic make-up may contribute to adverse reactions to drugs

Kim Ton thumbnail

Student profile

Kim Ton is developing a genetic screening test to identify those at a higher risk of serious drug reactions